Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» NEJM Editorial Raises Questions About Dendreon’s Cancer Vaccine Study: Biotech's Latest Mishaps
NEJM Editorial Raises Questions About Dendreon’s Cancer Vaccine Study: Biotech's Latest Mishaps
NEJM Editorial Raises Questions About Dendreon’s Cancer Vaccine Study: Biotech's Latest Mishaps
Submitted by
admin
on August 2, 2010 - 10:03am
Source:
Seeking Alpha
News Tags:
New England Journal of Medicine
Provenge
Dendreon
prostate cancer
Headline:
NEJM Editorial Raises Questions About Dendreon’s Cancer Vaccine Study: Biotech's Latest Mishaps
Do Not Allow Advertisers to Use My Personal information
